Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade

Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade

Limited evidence-based management guidelines for resectable intrahepatic cholangiocarcinoma (ICC) currently exist. Using a large population-based cancer registry; the utilization rates and outcomes for patients with clinical stages I-III ICC treated with neoadjuvant chemotherapy (NAT) in relation to...

Full description

Bibliographic Details
Main Authors: Rebecca Marcus, Wade Christopher, Jennifer Keller, Sean Nassoiy, Shu-Ching Chang, Melanie Goldfarb, Ronald Wolf, Zeljka Jutric
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
intrahepatic cholangiocarcinoma
neoadjuvant therapy
adjuvant therapy
National Cancer Database
Online Access:https://www.mdpi.com/2072-6694/14/17/4320

Internet

https://www.mdpi.com/2072-6694/14/17/4320

Similar Items